KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash & Equivalents: 2017-2024

Historic Cash & Equivalents for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $468.0 million.

  • Elanco Animal Health's Cash & Equivalents rose 3.06% to $505.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.0 million, marking a year-over-year increase of 3.06%. This contributed to the annual value of $468.0 million for FY2024, which is 32.95% up from last year.
  • Per Elanco Animal Health's latest filing, its Cash & Equivalents stood at $468.0 million for FY2024, which was up 32.95% from $352.0 million recorded in FY2023.
  • Elanco Animal Health's 5-year Cash & Equivalents high stood at $638.0 million for FY2021, and its period low was $345.0 million during FY2022.
  • Over the past 3 years, Elanco Animal Health's median Cash & Equivalents value was $352.0 million (recorded in 2023), while the average stood at $388.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first spiked by 48.20% in 2020, then crashed by 45.92% in 2022.
  • Over the past 5 years, Elanco Animal Health's Cash & Equivalents (Yearly) stood at $495.0 million in 2020, then increased by 28.89% to $638.0 million in 2021, then crashed by 45.92% to $345.0 million in 2022, then increased by 2.03% to $352.0 million in 2023, then skyrocketed by 32.95% to $468.0 million in 2024.